SeromYx Systems hosted a working session on building an antibody program with limited resources, tight timelines, and a small team on Monday 28 September at CIC Cambridge, Kendall Square.
Public source
Publisher name
Public post
Who decides what makes the cut? The people who have had to. 🎤 Here is the line-up for What Makes the Cut?, a working session on building an antibody program with limite…
Company
SeromYx Systems
Correlating Fc function with safety and efficacy
- Industry
- Biotechnology
- Location
- Woburn, US
- Company size
- 11–50 employees
About SeromYx Systems
SeromYx Systems, Inc. is a global leader in providing GCLP high-throughput antibody characterization and Systems Serology services, offering advanced solutions for the comprehensive analysis of immune responses and correlation of antibody function with clinical outcomes. With a dedication to innovation and excellence, SeromYx is at the forefront of revolutionizing the field of vaccine and therapeutic antibody development through its cutting-edge technologies and strategic collaborations. SeromYx is certified as compliant with GCLP, and performs studies in compliance with that standard.
See moreLatest activity
Latest activity from SeromYx Systems
4 signals
Presence & Recognition
SeromYx Systems is participating in the What Makes the Cut? symposium in Cambridge, MA on Monday, September 28, 2026, featuring AVS Bio, RoukenBio, and industry leaders.
Presence & Recognition
SeromYx Systems announced a webinar on Tuesday, September 15th at 11:00 am ET featuring Amanda Gross, Ph.D., analyzing antibody function and Fc biology using head-to-head comparisons of rituximab, ofatumumab, and obinutuzumab.
Research & Knowledge
SeromYx Systems contributed to a study published in npj Vaccines that explores protective antibody responses against RSV, including preF-binding IgG and neutralizing antibody levels.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
AVS Bio
AVS Bio hosted a working session on building an antibody program called What Makes the Cut? on Monday 28 September at the Cambridge Innovation Center.
Presence & Recognition
Immunologix Laboratories
Immunologix Laboratories is hosting its October 1st lineup featuring Dr. Lauren Stevenson's talk on COU-Driven ADA Biomarker Assay Validation at Le Méridien Boston in Cambridge.
Presence & Recognition
Cambridge Healthtech Institute
Cambridge Healthtech Institute hosted an expert panel of scientists discussing immunotherapy clinical outcomes, resistance mechanisms, survival rates, prediction models, rational combinations, and extending to other indications.
Presence & Recognition
FORMULATRIX
FORMULATRIX is hosting a hands-on workshop on Thursday, October 1st, 2026, in Bedford, MA, featuring a test drive of automation and real protocols.
Presence & Recognition
MabDesign